Tom Wilemon

April 23, 2020

Polygenic scores identify those at high cancer risk

A team of Vanderbilt researchers constructed polygenic risk scores (PRS) based on genomic variants associated with eight common cancers and concluded they could potentially be used for personalized risk assessments.

By Tom Wilemon
April 23, 2020

Study explores melanoma drug’s effectiveness

A study by Vanderbilt research-ers supports the clinical development of a new second-line treatment for metastatic melanoma.

By Tom Wilemon
April 9, 2020

Study tracks genomics of lung tumor behavior

A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.

By Tom Wilemon
April 3, 2020

Shinohara named chair of the Department of Radiation Oncology

After serving as the department’s interim leader, Eric Shinohara, MD, MSCI, vice chair of the Department of Radiation Oncology at Vanderbilt University Medical Center, has been named as the department’s chair.

By Tom Wilemon
April 2, 2020

Researcher works on protocols to implement screening for gastric cancer

A Vanderbilt gastroenterologist is helping lead an effort to establish screening guidelines for gastric cancer in the United States, where the number of people at risk for the cancer is increasing as the nation’s population becomes more diverse.

By Tom Wilemon
March 23, 2020

Study reveals an inherited origin of prostate cancer in families

Vanderbilt researchers have identified haplotypes, ancestral fragments of DNA, that are associated with hereditary prostate cancer (HPC) in a first-of-its-kind genomic study made possible by the study of prostate cancer patients with family histories of the disease.

By Tom Wilemon
March 13, 2020

Thurman Stevens takes extra steps to ease patients’ anxiety

Stevens said he stays on the lookout for patients who may need some extra help.
By Tom Wilemon
March 12, 2020

Triple-negative breast cancer drug therapy shows promise

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.
By Tom Wilemon
March 12, 2020

VICC’s Knoop elected to Oncology Nursing Society board of directors

Teresa Knoop, MSN, RN, assistant director of Clinical Operations for the Clinical Trials Office at Vanderbilt-Ingram Cancer Center (VICC), has been elected to the board of directors of the Oncology Nursing Society.
By Tom Wilemon
March 5, 2020

Das lands support for neuroendocrine tumor research

Satya Das, MD, has been awarded a $300,000 grant for a two-year period by the Neuroendocrine Tumor Research Foundation.
By Tom Wilemon
February 27, 2020

Patient’s cancer treatment includes new immunotherapy

Dona Potter, 87, rode Harleys and drove 18-wheelers back when men dominated the open highways, and she is still defying expectations.
By Tom Wilemon
February 20, 2020

Symposium to focus on stem cell transplant, cellular therapies

New therapies that re-engineer patients’ T-cells to target cancer and advances in stem cell transplantations that make it easier for patients to be matched with donors are among the topics at an upcoming symposium.
By Tom Wilemon
1 … 20 21 22 23 24 … 39